3 ms·
1. There is little to nothing preventing competitors, though I would be surprised if anyone can compete with us on price. 2. I agree. A startup is inherently r
by ingenium 19y ago
1. There is little to nothing preventing competitors, though I would be surprised if anyone can compete with us on price.
2. I agree. A startup is inherently risky and we are taking every precaution we can.
3. Error rates are effectively 0% as far as the technique goes. The only possibility of error is human error in handling. Our testing procedures are specifically designed to minimize the risk of human error. Furthermore, due to the nature of the testing procedure, any possible errors would result in false negatives, not false positives. In addition, we have a policy of retesting all positive results.
4. Noted, thanks... it does the same thing in Safari also.
- timr 19y agoI'm suspicious of your claims in 3. What method are you using? Certainly not RFLP, right? Are you sequencing the gene? A labeled oligonucleotide, targeted toward the deletion? I'm having a hard time conceiving of a method with zero error rate (either type I or II).